Drug-coated stents

Beginning of the end for this troubled technology?

This week’s installment in drug-coated stents’ never-ending tale of woe comes from Britain, where the National Health Service could soon stop paying for the devices altogether.

A recent report commissioned by the government found that drug-coated stents, which cost about $2,300, aren’t worth the extra money compared to older bare metal stents, which cost about $700.

Related posts:

1. Drug-eluting stents
2. Marketing stents to consumers
3. Stents take a hit
4. "Avoiding drug companies and their advertisements is not the answer"
5. The waning effect of direct to consumer drug advertising
6. Medical device ads
7. "Without drug reps, we’d have the meeting in the basement of some hospital"

  Follow on Twitter   Subscribe